Skip to Content

First Trust NYSE Arca Biotech ETF FBT ETF Analysis

| Medalist Rating as of | See First Trust Investment Hub

Morningstar’s Analysis FBT

Will FBT outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

The combination of an Average People Pillar rating and a Below Average Process Pillar rating limit First Trust NYSE Arca Biotech ETF to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor